vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and KFORCE INC (KFRC). Click either name above to swap in a different company.
AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $330.4M, roughly 1.1× KFORCE INC). KFORCE INC runs the higher net margin — 2.4% vs -0.8%, a 3.2% gap on every dollar of revenue. On growth, AdvanSix Inc. posted the faster year-over-year revenue change (9.4% vs 0.1%). AdvanSix Inc. produced more free cash flow last quarter ($36.1M vs $-7.4M). Over the past eight quarters, AdvanSix Inc.'s revenue compounded faster (3.4% CAGR vs -3.7%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
Kforce Inc. is a professional staffing and solutions firm headquartered in the United States. It provides skilled professional placements and specialized workforce solutions primarily across technology, finance & accounting, and healthcare segments, serving a wide range of mid-sized to large enterprise clients nationwide.
ASIX vs KFRC — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $330.4M |
| Net Profit | $-2.8M | $7.9M |
| Gross Margin | 7.6% | 27.3% |
| Operating Margin | -0.7% | 3.6% |
| Net Margin | -0.8% | 2.4% |
| Revenue YoY | 9.4% | 0.1% |
| Net Profit YoY | -892.9% | -2.7% |
| EPS (diluted) | $-0.11 | $0.46 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $330.4M | ||
| Q4 25 | $359.9M | $332.0M | ||
| Q3 25 | $374.5M | $332.6M | ||
| Q2 25 | $410.0M | $334.3M | ||
| Q1 25 | $377.8M | $330.0M | ||
| Q4 24 | $329.1M | $343.8M | ||
| Q3 24 | $398.2M | $353.3M | ||
| Q2 24 | $453.5M | $356.3M |
| Q1 26 | — | $7.9M | ||
| Q4 25 | $-2.8M | $5.2M | ||
| Q3 25 | $-2.6M | $11.1M | ||
| Q2 25 | $31.4M | $10.4M | ||
| Q1 25 | $23.3M | $8.1M | ||
| Q4 24 | $352.0K | $11.1M | ||
| Q3 24 | $22.3M | $14.2M | ||
| Q2 24 | $38.9M | $14.2M |
| Q1 26 | — | 27.3% | ||
| Q4 25 | 7.6% | 27.2% | ||
| Q3 25 | 6.8% | 27.7% | ||
| Q2 25 | 14.3% | 27.1% | ||
| Q1 25 | 14.2% | 26.7% | ||
| Q4 24 | 3.4% | 27.0% | ||
| Q3 24 | 14.4% | 27.9% | ||
| Q2 24 | 17.9% | 27.8% |
| Q1 26 | — | 3.6% | ||
| Q4 25 | -0.7% | 2.6% | ||
| Q3 25 | -0.9% | 4.5% | ||
| Q2 25 | 7.7% | 4.5% | ||
| Q1 25 | 7.7% | 3.5% | ||
| Q4 24 | -3.9% | 4.5% | ||
| Q3 24 | 7.5% | 5.3% | ||
| Q2 24 | 11.5% | 5.5% |
| Q1 26 | — | 2.4% | ||
| Q4 25 | -0.8% | 1.6% | ||
| Q3 25 | -0.7% | 3.3% | ||
| Q2 25 | 7.7% | 3.1% | ||
| Q1 25 | 6.2% | 2.5% | ||
| Q4 24 | 0.1% | 3.2% | ||
| Q3 24 | 5.6% | 4.0% | ||
| Q2 24 | 8.6% | 4.0% |
| Q1 26 | — | $0.46 | ||
| Q4 25 | $-0.11 | $0.29 | ||
| Q3 25 | $-0.10 | $0.63 | ||
| Q2 25 | $1.15 | $0.59 | ||
| Q1 25 | $0.86 | $0.45 | ||
| Q4 24 | $0.02 | $0.60 | ||
| Q3 24 | $0.82 | $0.75 | ||
| Q2 24 | $1.43 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | $1.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $815.2M | $117.4M |
| Total Assets | $1.7B | $384.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $1.3M | ||
| Q4 25 | $19.8M | $2.1M | ||
| Q3 25 | $23.7M | $1.3M | ||
| Q2 25 | $18.4M | $2.5M | ||
| Q1 25 | $8.3M | $444.0K | ||
| Q4 24 | $19.6M | $349.0K | ||
| Q3 24 | $17.3M | $127.0K | ||
| Q2 24 | $12.1M | $110.0K |
| Q1 26 | — | $117.4M | ||
| Q4 25 | $815.2M | $124.6M | ||
| Q3 25 | $818.2M | $132.1M | ||
| Q2 25 | $823.7M | $134.4M | ||
| Q1 25 | $794.4M | $138.0M | ||
| Q4 24 | $774.6M | $154.6M | ||
| Q3 24 | $766.4M | $167.4M | ||
| Q2 24 | $746.6M | $166.6M |
| Q1 26 | — | $384.8M | ||
| Q4 25 | $1.7B | $365.6M | ||
| Q3 25 | $1.7B | $374.2M | ||
| Q2 25 | $1.6B | $373.6M | ||
| Q1 25 | $1.6B | $368.2M | ||
| Q4 24 | $1.6B | $357.8M | ||
| Q3 24 | $1.5B | $369.9M | ||
| Q2 24 | $1.5B | $362.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | — |
| Free Cash FlowOCF − Capex | $36.1M | $-7.4M |
| FCF MarginFCF / Revenue | 10.0% | -2.2% |
| Capex IntensityCapex / Revenue | 7.7% | 1.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | $43.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $63.7M | $19.7M | ||
| Q3 25 | $26.6M | $23.3M | ||
| Q2 25 | $21.1M | $18.4M | ||
| Q1 25 | $11.4M | $249.0K | ||
| Q4 24 | $64.2M | $21.8M | ||
| Q3 24 | $57.3M | $31.0M | ||
| Q2 24 | $50.2M | $20.9M |
| Q1 26 | — | $-7.4M | ||
| Q4 25 | $36.1M | $16.7M | ||
| Q3 25 | $66.0K | $19.8M | ||
| Q2 25 | $-7.2M | $14.2M | ||
| Q1 25 | $-22.6M | $-3.9M | ||
| Q4 24 | $29.8M | $20.9M | ||
| Q3 24 | $26.8M | $27.5M | ||
| Q2 24 | $16.7M | $17.8M |
| Q1 26 | — | -2.2% | ||
| Q4 25 | 10.0% | 5.0% | ||
| Q3 25 | 0.0% | 6.0% | ||
| Q2 25 | -1.7% | 4.3% | ||
| Q1 25 | -6.0% | -1.2% | ||
| Q4 24 | 9.1% | 6.1% | ||
| Q3 24 | 6.7% | 7.8% | ||
| Q2 24 | 3.7% | 5.0% |
| Q1 26 | — | 1.0% | ||
| Q4 25 | 7.7% | 0.9% | ||
| Q3 25 | 7.1% | 1.1% | ||
| Q2 25 | 6.9% | 1.2% | ||
| Q1 25 | 9.0% | 1.3% | ||
| Q4 24 | 10.4% | 0.3% | ||
| Q3 24 | 7.7% | 1.0% | ||
| Q2 24 | 7.4% | 0.9% |
| Q1 26 | — | — | ||
| Q4 25 | — | 3.82× | ||
| Q3 25 | — | 2.11× | ||
| Q2 25 | 0.67× | 1.76× | ||
| Q1 25 | 0.49× | 0.03× | ||
| Q4 24 | 182.29× | 1.97× | ||
| Q3 24 | 2.57× | 2.18× | ||
| Q2 24 | 1.29× | 1.48× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
KFRC
Segment breakdown not available.
